Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Where cell and gene therapy companies are finding management talent

Demand outstrips supply, pushing newcos to go outside the field, tap first-time leaders for the top jobs

October 11, 2022 8:33 PM UTC

Relatively new and light on incumbents, the expanding cell and gene therapy field is brimming with leadership opportunities. With the first generation executives mostly sticking together rather than spreading out, the latest class of start-ups is being pushed to seek management talent in diverse places.

BioCentury’s analysis of the management teams at 35 of the newest cell and gene therapy companies — those that announced a series A financing in the past 15 months — shows the majority are building their C-suites with candidates from the outside the field. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article